ReviewCurrent pharmaceutical design2025

Pyrimidine: A Privileged Scaffold for the Development of Anticancer Agents as Protein Kinase Inhibitors (Recent Update).

Mai M Zeid et al.PubMed ↗Publisher ↗

No numbers read from the abstract.